4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Bafilomycin A<sub>1</sub> (high purity)/BVT-0252-C100/100 µg
商品详细Adipogen/Bafilomycin A<sub>1</sub> (high purity)/BVT-0252-C100/100 µg
Adipogen/Bafilomycin A<sub>1</sub> (high purity)/BVT-0252-C100/100 µg
Adipogen/Bafilomycin A<sub>1</sub> (high purity)/BVT-0252-C100/100 µg
商品编号: BVT-0252-C100
品牌: Adipogen Inc
市场价: ¥1600.00
美元价: 960.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
SynonymsNSC381866
ProductTypeChemical
Properties
FormulaC35H58O9
MW622.8
CAS88899-55-2
Source/HostChemicalsIsolatedfromStreptomycesgriseus.
PurityChemicals≥98%(HPLC)
AppearanceWhitetooff-whitepowder.
SolubilitySolubleinDMSO,100%ethanolormethanol.
IdentityDeterminedby1H-NMR.
DeclarationManufacturedbyBioViotica.
InChiKeyXDHNQDDQEHDUTM-AZJYDCQCSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceProtectfromlightwheninsolution.
Use/StABIlityStableforatleast1yearafterreceiptwhenstoredat-20°C.
Afterreconstitutionprotectfromlightat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Macrolideantibiotic.
  • Specificvacuolar-typeH+-ATPaseinhibitor.
  • DistinguishesamongdifferenttypesofATPases.
  • Inhibitorofendosomal,lysosomalandvacuolaracidification.
  • PreventslysosomalCa2+uptake.
  • InhibitorofautophagicdegradationbyrisingpHandthus inactivatingthelysosomalacidhydrolases.
  • Neuroprotective.
ProductReferences
  1. Metabolicproductsofmicroorganisms.224.Bafilomycins,anewgroupofmacrolideantibiotics.Production,isolation,chemicalstructureandBIOLOGicalactivity:G.Werner,etal.;J.Antibiot.37,110(1984)
  2. Bafilomycins:aclassofinhibitorsofmembraneATPasesfrommicroorganisms,animalcells,andplantcells:E.J.Bowman,etal.;PNAS85,7972(1988)
  3. InhibitionofosteoclastprotontransportbybafilomycinA1abolishesboneresorption:K.Sundqui,etal.;BBRC168,309(1990)
  4. KineticstudiesofchromaffingranuleH+-ATPaseandeffectsofbafilomycinA1:H.Hanada,etal.;BBRC170,873(1990)
  5. BafilomycinA1inhibitsthetargetingoflysosomalacidhydrolasesinculturedhepatocytes:K.Oda,etal.;BBRC178,369(1991)
  6. BafilomycinA1,aspecificinhibitorofvacuolar-typeH(+)-ATPase,inhibitsacidificationandproteindegradationinlysosomesofculturedcells:T.Yoshimori,etal.;J.Biol.Chem.266,17707(1991)
  7. BafilomycinA1,aspecificinhibitorofvacuolar-typeH(+)-ATPase,blockslysosomalcholesteroltraffickinginmacrophages:T.Furuchi,etal.;J.Biol.Chem.268,27345(1993)
  8. Cell-typeandamyloidprecursorprotein-typespecificinhibitionofAbetareleasebybafilomycinA1,aselectiveinhibitorofvacuolarATPases:J.Knops,etal.;J.Biol.Chem.270,2419(1995)
  9. Autophagy,bafilomycinandcelldeath:the"a-B-cs"ofplecomacrolide-inducedneuroprotection:J.J.Shacka,etal.;Autophagy2,228(2006),(Review)
  10. BafilomycinA1-sensitivepathwayisrequiredforthematurationofcysticfibrosistransmembraneconductanceregulator:T.Okiyoneda,etal.;Biochim.Biophys.Acta1763,1017(2006)
  11. Ectopicvesicularneurotransmitterreleasealongsensoryaxonsmediatesneurovascularcouplingviaglialcalciumsignaling:A.Thyssen,etal.;PNAS107,15258(2010)
  12. Low-doseBafilomycinattenuatesneuronalcelldeathassociatedwithautophagy-lysosomepathwaydysfunction:V.N.Pivtoraiko,etal.;J.NeuRochem.114,1193(2010)
  13. Alterationsinosteoclastfunctionandphenotypeinducedbydifferentinhibitorsofboneresorption-implicationsforosteoclastquality:A.V.Neutzsky-Wulff,etal.;BMCMusculoskeletalDisorders11, 109(2010)
  14. RapidrecyclingofCa2+betweenIP3-sensitivestoresandlysosomes:C.I.LopezSanjurjo,etal.;PLoSOne9,e111275/1(2014)
  15. BafilomycinA1inhibitsautophagyandinducesapoptosisinMG63osteosarcomacells:Z.Xie,etal.;Mol.Med.Rep.10,1103(2014)
  16. Comparisonofthechemoimmunotherapeuticeffectofdoxorubicinandbafilomycin-A1inmouseneuroblastomacells:S.Inoue,etal.;GanToKagakuRyoho.Cancer&Chemotherapy41,617(2014)
  17. SuppressionofinfluenzaAvirusreplicationinhumanlungepithelialcellsbynoncytotoxicconcentrationsBafilomycinA1:B.Y,etal.;Am.J.Physiol.LungCellMol.Physiol.308,L270(2015)
  18. BafilomycinA1targetsbothautophagyandapoptosispathwaysinpediatricB-cellacutelymphoblasticleukemia:N.Yuan,etal.;Haematologica100,345(2015)
  19. TheprotectiveeffectofbafilomycinA1againstcobaltnanoparticle-inducedcytotoxityandasepticinflammationinmacrophagesinvitro:S.Wang,etal.;Biol.TraceElem.Res.(2015)
  20. SuppressionofinfluenzaAvirusreplicationinhumanlungepithelialcellsbynoncytotoxicconcentrationsBafilomycinA1:B.Yeganeh,etal.;Am.J.Physiol.308,L270(2015)
  21. Age-dependentchangesinsynapticplasticityenhancetauoligomerizationinthemousehippocampus:T.Kimura,etal.;ActaNeuropathol.Comm.5,67(2017)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。